This content is from: United States
US tax reform incentivises IP strategy considerations
The US is increasingly becoming attractive again to IP-rich companies, especially large US pharmaceuticals and technology multinationals. Deductions from foreign-derived income attributable to intangibles (FDII) serve as a carrot, but other provisions in the tax code may yet impact the cost of relocating assets.
To access our market-driven intelligence please request a trial here.
Read this article – and more – for a one-week period.
REQUEST ACCESSAre you already an ITR subscriber? Log in here